While single-use systems are common in mammalian cell culture, their adoption in microbial fermentation has been slower due to the high demands of oxygen transfer and cooling. ABEC’s Custom Single Run (CSR®) technology
Resources
Catalogue
At BIOVECTRA, we’re committed to advancing your bioprocessing capabilities, and our selection of high-quality bioprocessing reagents is here to make it happen. Whether you’re in the early stages of research…
On-Demand Webinar
ADCs are an advanced approach in the field of biomedicine that aims to target and treat various diseases in innovative ways, though there are often challenges which require innovative solutions for development […]
Video
Join Bryan Lowery, VP & GM mRNA Vaccine and pDNA Operations, as he unveils our new, cutting-edge biomanufacturing facility, set to open its doors in late 2023. […]
Article
The recent resurgence in microbial fermentation for biologics production can be attributed to many factors. Advances in biochemistry and a growing understanding of when glycosylation is not needed […]
Article
Drug development, regardless of the modality, invariably involves some level of risk. As mRNA therapeutics advance, they too will face such risks, including some […]
Article
The outlook for mRNA vaccines and therapeutics continues to be promising, with demand expected to increase as many candidates move into late-stage clinical development and on toward commercialization. With […]
Interview
BIOVECTRA is a global CDMO with a 52 year history – and a one stop shop for our clients. Our growth, in recent years, has been explosive and we’ve made big moves into biologics in recent years. Our new mRNA and Biomanufacturing facility opens […]
Article
Pharmaceutical supply chains are susceptible to sudden changes in demand or disruptions in what is still largely a centralized manufacturing system. This was highlighted during the COVID-19 pandemic, when access to vaccines, medications and test […]
Article
BIOVECTRA, a CDMO based in Atlantic Canada has established its presence in the industry – and it is not slowing down any time soon. From its experience providing diagnostic reagents, enzymes and APIs, it has over the past five decades evolved it’s product […]
Interview
Since the beginning of the COVID-19 pandemic, pharmaceutical organizations have experienced major changes, a prime example of which has been the rising requirement for collaborations on multiple different fronts across the industry […]
Article
Biologics have revolutionized drug delivery, offering innovative therapies for a range of diseases, including cancers, autoimmune and other genetic disorders, and infectious diseases. To meet booming demand […]
With over 50 years of experience, we are a forward-thinking,
North American CDMO specializing in clinical-to-commercial scale production of high-quality regulated APIs and Intermediates.